CFO Litchfield Caroline sold 41,997 shares of MRK at $119.61 on 2026-02-04; stock now trading at $121.93, near 52-week high.
Litchfield Caroline, EVP & CFO of Merck & Co., Inc., sold 41,997 shares at $119.61, reducing her holdings by -31.8% from 132,189 to 90,192 shares and raising $5,023,311.57. MRK has appreciated +12.3% over 30 days and +41.3% over 90 days, now trading at $121.93, which is at the 52-week high of $121.93. Against this backdrop of substantial recent gains, the sale represents a significant reduction in her concentrated position. Notably, her prior sell at MRK on 2024-02-14 was poorly timed (the stock gained +2.5% over the ensuing 90 days), and her cross-ticker track record shows 0 of 1 prior sales were well-timed at the 90-day mark with an average 90-day return of +2.5% after sells. The company's fundamentals remain solid with annual revenue growth of +6.7% and a P/E of 15.90, though the timing of this sale at near 52-week highs after significant near-term appreciation warrants attention to whether the CFO sees valuation headwinds.